Analysis instructions for PET radiopharmaceuticals

Researchers of Turku PET Centre should also read specific instructions for quantitative analysis methods in the SOPs and METs in TPC intranet.

Note: This is not the list of radiopharmaceuticals that are available in Turku PET Centre. Instead, this is the list of radiopharmaceuticals which TPC modelling group has been run into, either locally or in collaboration with other centres, or because of review assignments. You may find the Molecular Imaging and Contrast Agent Database more useful than this.

[¹⁵O] radiopharmaceuticals

• [¹⁵O]CO
• [¹⁵O]CO₂
• [¹⁵O]H₂O (radiowater)
  • Cerebral blood flow
  • Renal blood flow
  • Myocardial blood flow
  • Pancreatic blood flow
  • Muscle blood flow
  • Blood flow in other organs
• [¹⁵O]O₂ (oxygen gas)
  • Metabolic rate of oxygen in the brain
  • Regional metabolic rate of oxygen in the skeletal muscle
  • Metabolic rate of oxygen in the myocardium
  • Metabolic rate of oxygen in BAT (draft)

[¹¹C] radiopharmaceuticals

• [¹¹C]acetate
• [1-¹¹C]acetoacetate
• [¹¹C]carfentanil
• [¹¹C]CFT
• [¹¹C]choline
• [¹¹C]CIT
• [¹¹C]CO₂
• [¹¹C]L-deprenyl-D2
• [¹¹C]DOPA
• [¹¹C]FLB 457 (draft)
• [¹¹C]flumazenil
• R-β-[1-¹¹C]hydroxybutyrate
• [¹¹C]lactate
• [¹¹C]MADAM
• [¹¹C]MeAIB
• [¹¹C]metformin
• L-[¹¹C]methionine
• [¹¹C]Metomidate ([¹¹C]MTO)
• [¹¹C]HED
• [¹¹C]MPDX (draft)
• [¹¹C]MP4A: AChE activity in the brain (draft)
• [¹¹C]MP4B: BuChE activity in the brain (draft)
• [¹¹C]NMSP
• [¹¹C]NNC 756
• [¹¹C]ORM-13070
• [¹¹C]palmitate
• [¹¹C]PBR28
• [¹¹C]PE2I
• [¹¹C]PIB
• [¹¹C]-R-PK11195
• [¹¹C]raclopride
• [¹¹C]SCH 23390
• [¹¹C]SCH 39166
• [¹¹C]SMW139
• [¹¹C]UCB-J
• [carbonyl-¹¹C]WAY-100635
• [¹¹C]TMSX

[¹⁸F] radiopharmaceuticals

• [¹⁸F]Altanserin
• [¹⁸F]Flurpiridaz (BMS-747158-02)
• [¹⁸F]CFT
• [¹⁸F]DPA-714
• [¹⁸F]EF5
• [¹⁸F]Deuteroaltanserin
• [¹⁸F]Exendin-4
• [¹⁸F]FBPA
• [¹⁸F]FDG
• [¹⁸F]FDOPA
  • NET and [¹⁸F]FDOPA: TPCMOD0018 (draft)
• [¹⁸F]FEMPA
• [¹⁸F]FETNIM (replaced by [¹⁸F]EF5)
• [¹⁸F]FACBC (fluciclovine)
• [¹⁸F]Fluoride
• [¹⁸F]fluorodopamine
• (2S,4R)-4-[¹⁸F]fluoroglutamine ([¹⁸F]FGln)
• [¹⁸F]FLT
• [¹⁸F]fluoromannan
• [¹⁸F]flutemetamol
• [¹⁸F]FMPEP-d₂
• [¹⁸F]FTHA
• [¹⁸F]MFBG
• [¹⁸F]NS12137
• [¹⁸F]PE2I
• [¹⁸F]PSMA-1007
• [¹⁸F]SPA-RQ
• [¹⁸F]THK-5117

[⁶⁸Ga] radiopharmaceuticals

• [⁶⁸Ga]citrate
• ⁶⁸Ga-DOTA
• [⁶⁸Ga]-DOTA-E-[c(RGDfK)]₂(draft)
• [⁶⁸Ga]DOTANOC
• [⁶⁸Ga]DOTATOC
• [⁶⁸Ga]NODAGA-exendin-4
• [⁶⁸Ga]PSMA-11 ([⁶⁸Ga]PSMA-HBED-CC)

[¹³N] radiopharmaceuticals

• [¹³N]ammonia

[⁸²Rb]

• ⁸²Rb

[⁶⁴Cu] radiopharmaceuticals

• [⁶⁴Cu]CuCl₂

[¹²⁴I] radiopharmaceuticals

• ¹²⁴I radiopharmaceuticals are not routinely used in TPC

[⁸⁹Zr] radiopharmaceuticals

• ⁸⁹Zr radiopharmaceuticals are in routine use in TPC

Tags: Analysis, Modeling, PET, Tracer

---

Updated at: 2021-11-30
Created at: 2009-06-25
Written by: Vesa Oikonen